<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04811157</url>
  </required_header>
  <id_info>
    <org_study_id>2014-2020.4.02.19-0198</org_study_id>
    <nct_id>NCT04811157</nct_id>
  </id_info>
  <brief_title>The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota</brief_title>
  <official_title>The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center of Food and Fermentation Technologies</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SYNLAB Eesti OÜ, Tallinn, Estonia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AS FARMI Piimatööstus, Jõhvi, Estonia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Center of Food and Fermentation Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this dietary intervention is to study the effects of dietary fibers on the gut&#xD;
      microbiota and use yoghurt as the carrier.&#xD;
&#xD;
      Hypothesis 1: Intake of dietary fibers improves the blood lipid profile of the participants.&#xD;
&#xD;
      Hypothesis 2: Intake of dietary fibers stabilizes the gut microbiome (e.g., low diversity) of&#xD;
      the participants, improves gut health and normalizes gastrointestinal function and bowel&#xD;
      habits.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design is a parallel randomized, prospective, pre-post intervention trial. The main&#xD;
      goal of this study is to investigate the effect of the dietary fibers in an unsweetened&#xD;
      yoghurt. Fermented dairy products have naturally a very low dietary fiber content, but such&#xD;
      products can be supplemented with variety of dietary fibers and promote the growth of&#xD;
      beneficial gut bacteria. Also, as fermented milk products contain live bacteria, it is&#xD;
      possible that prebiotic fibers could support the growth of the starter-culture based strains&#xD;
      in the human gut.&#xD;
&#xD;
      PRE-STUDY EVALUATION AND TESTING&#xD;
&#xD;
        1. Complete pre-study questionnaire&#xD;
&#xD;
        2. Complete orientation to the study and provide voluntary consent to join the study&#xD;
&#xD;
        3. Collection of coded intervention products, sampling supplies, and instructional&#xD;
           materials 0-WEEK QUESTIONNAIRE AND LABORATORY VISIT&#xD;
&#xD;
      1. Record food intake and gastrointestinal function for 3 days 2. Collect health data and&#xD;
      provide a 3-day food frequency questionnaire 3. Provide a stool and blood sample at the&#xD;
      laboratory 2-WEEK QUESTIONNAIRE AND LABORATORY VISIT&#xD;
&#xD;
        1. Record food intake and gastrointestinal symptoms for 3 days&#xD;
&#xD;
        2. Collect health data and provide a 3-day food frequency questionnaire&#xD;
&#xD;
        3. Provide a stool and blood sample at the laboratory BLOOD SAMPLE ANALYSES&#xD;
&#xD;
      1. Provide the blood sample at the laboratory in the morning in an overnight fasted state.&#xD;
&#xD;
      DIETARY INTERVENTION&#xD;
&#xD;
      1. Daily intake of a test or control product for two weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Actual">August 31, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the intestinal microbiota</measure>
    <time_frame>14 days</time_frame>
    <description>Fecal microbiota analysis based on the 16S rRNA sequencing pre- and post-dietary intervention.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of blood lipid profile</measure>
    <time_frame>14 days</time_frame>
    <description>Triglycerides, total cholesterol, HDL-cholesterol, LDL-cholesterol pre- and post-dietary intervention in plasma (mmol/L).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of blood glucose levels</measure>
    <time_frame>14 days</time_frame>
    <description>Fasting glucose pre- and post-dietary intervention in plasma (mmol/L).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the stool form</measure>
    <time_frame>14 days</time_frame>
    <description>Stool form will be assessed using a validated 7-point scale called Bristol Stool Form Scale pre- and post-dietary intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the defecation frequency</measure>
    <time_frame>14 days</time_frame>
    <description>Evacuation frequency during 3 days pre- and post-dietary intervention.&#xD;
Evacuation frequency (number of bowel movements per week) pre- and post-dietary intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the defecation timing</measure>
    <time_frame>14 days</time_frame>
    <description>Evacuation timing 3 days before sampling pre- and post-dietary intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the gastrointestinal symptoms</measure>
    <time_frame>14 days</time_frame>
    <description>Frequency and severity of the gastrointestinal symptoms (Constipation, Diarrhea, Bloating, Flatulence, Cramps, Stomach pain). Scale of frequency: Never, Less than 10 times a year, Once a month, Once a week, Every day. Scale of severity: I do not have any gastrointestinal symptoms, Mild (does not disturb), Moderate, Strong (disturbs considerably).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the blood vitamin D status</measure>
    <time_frame>14 days</time_frame>
    <description>25-OH vitamin D pre- and post-dietary intervention in plasma.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Test group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy adults consuming test product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Healthy adults consuming control product</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Test product</intervention_name>
    <description>200 g/day of unsweetened yogurt supplemented with a dietary fiber blend</description>
    <arm_group_label>Test group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control product</intervention_name>
    <description>200 g/day of unsweetened yogurt</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 25-55&#xD;
&#xD;
          -  Normal bowel function&#xD;
&#xD;
          -  Regular consumer of dairy products, willing to consume dairy products daily for 2&#xD;
             weeks&#xD;
&#xD;
          -  Ability to provide a signed written informed consent&#xD;
&#xD;
          -  Willing to provide stool and blood specimens 2 times over the 2-week study period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosed history of chronic diseases including coronary heart disease, stroke,&#xD;
             cancer, type 1 or 2 diabetes mellitus, inflammatory bowel disease, gastritis,&#xD;
             autoimmune disease, or rheumatoid arthritis&#xD;
&#xD;
          -  Medication: statins, blood pressure medications, antidepressants, other prescription&#xD;
             medications&#xD;
&#xD;
          -  History of bariatric operation, removal of the gallbladder.&#xD;
&#xD;
          -  Food allergies, lactose intolerance&#xD;
&#xD;
          -  Recent (previous 3 months) use of antibiotics&#xD;
&#xD;
          -  Intake of highly dosed pre- or probiotics 2 weeks prior and during the study&#xD;
&#xD;
          -  Current pregnancy or breastfeeding&#xD;
&#xD;
          -  Volunteers showing previously unrecognized illness will also be excluded&#xD;
&#xD;
          -  Individual unable to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Madis Jaagura, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>TFTAK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center of Food and Fermentation Technologies</name>
      <address>
        <city>Tallinn</city>
        <state>Harjumaa</state>
        <zip>12618</zip>
        <country>Estonia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Estonia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 18, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Center of Food and Fermentation Technologies</investigator_affiliation>
    <investigator_full_name>Madis Jaagura</investigator_full_name>
    <investigator_title>Project Manager</investigator_title>
  </responsible_party>
  <keyword>microbiome</keyword>
  <keyword>bifidobacteria</keyword>
  <keyword>fermented dairy product</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Anonymized participant data could be made available for subsequent analysis in the mentioned institution (TFTAK).&#xD;
Data made public will include only aggregates or summaries of the collected data.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 11, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT04811157/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

